Discover trends, market shifts, and competitive outlooks for the large and small-scale bioprocessing industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What Are the Key Projections for the CAGR of the Large And Small-Scale Bioprocessing Market Size From 2025 to 2034?
Over the past few years, the market size of both large and small-scale bioprocessing has expanded significantly. The estimated growth is from $59.63 billion in 2024 to $67.85 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 13.8%. Factors such as expansion in the medical arena, implementation of regulatory norms, innovations in technology, advancements in biotechnology and the pharmaceutical sector, as well as food safety issues, have contributed to this historical upsurge.
Anticipated swift expansion is predicted for the large and small-scale bioprocessing market in the near future. The market is projected to attain a value of $112.2 billion in 2029, progressing at a compound annual growth rate (CAGR) of 13.4%. The rise in this span can be attributed to factors such as the escalation in healthcare spending, growth of pharmaceutical and biotechnology industries, technological innovation, regulatory constraints, growing awareness regarding food safety, and the impact of the COVID-19 pandemic. Significant trends during this anticipated timeframe include embracing of sophisticated technologies, territorial expansion, outsourced sterilization services, practices centered on sustainability, integration of sterilization techniques, and tailored sterilization solutions.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15845&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Large And Small-Scale Bioprocessing Market?
The increasing need for biologics is predicted to spur the expansion of the large and small-scale bioprocessing market in the future. Biologics are medicinal substances made from living organisms or their components, which include vaccines, blood and its components, gene therapies, tissues, and recombinant therapeutic proteins. The rising demand for these substances is due to advancements in biotechnology, a growing knowledge of disease processes, and the need for personalized and targeted treatments. Both large and small-scale bioprocessing are key to the successful development and commercialization of biologics. Small-scale bioprocessing is crucial for early development, optimization, and feasibility studies, while large-scale bioprocessing ensures efficient, consistent production of biologics that meet regulatory standards for commercial distribution. For example, as stated by the National Library of Medicine in February 2024, the Food and Drug Administration (FDA) approved 55 new drugs in 2023, including 29 new chemical entities (NCEs) and 25 new biological entities (NBEs). This represents a 50% increase from the 37 approvals in 2022. Consequently, the increasing demand for biologics fuels the expansion of the large and small-scale bioprocessing market.
Which Segments in the Large And Small-Scale Bioprocessing Offer the Most Growth?
The large and small-scale bioprocessing market covered in this report is segmented –
1) By Product: Bioreactors Or Fermenters, Cell Culture Products, Filtration Assemblies, Bioreactors Accessories, Bags And Containers, Other Products
2) By Mode: In-house, Outsourced
3) By Workflow: Downstream Processing, Fermentation, Upstream Processing
4) By Scale: Industrial Scale, Small Scale
5) By Application: Biopharmaceuticals, Specialty Industrial Chemicals, Environmental Aids
Subsegments:
1) Bioreactors Or Fermenters: Single-Use Bioreactors, Stainless Steel Bioreactors, Glass Bioreactors
2) Cell Culture Products: Cell Culture Media, Sera And Supplements, Reagents
3) Filtration Assemblies: Membrane Filters, Depth Filters, Tangential Flow Filtration Systems
4) Bioreactor Accessories: Spargers, Impellers, Sensors And Probes
5) Bags And Containers: Single-Use Bags, Storage Containers, Transfer Bags
6) Other Products: Mixers, Tubing And Connectors, Sampling Systems
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=15845&type=smp
Which Areas Are Leading Regions in the Large And Small-Scale Bioprocessing Market Expansion Across the Globe?
North America was the largest region in the large and small-scale bioprocessing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large and small-scale bioprocessing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Key Market Trends and Innovations Are Shaping the Future of the Large And Small-Scale Bioprocessing Industry?
Leaders in the bioprocessing market, both on a large and small scale, are unveiling innovative products like single-use centrifuge systems to better cater to their customers with superior features. These systems, which are disposable and pre-sterilized, are specially designed to separate biological materials in bioprocessing. An illustration of such innovation is the introduction of the DynaSpin Single-Use Centrifuge system by Thermo Fisher Scientific Inc., a biotechnology firm based in the US, in September 2022. This system has been created with the objective to enhance the efficiency of large-scale cell culture harvesting by simplifying the separation process, therefore reducing the number of depth filtration cartridges required. It also offers other advantages like increased product yield, operational efficiency, cost-effectiveness and sustainability in biologics production. The system is environmentally friendly as well, as it significantly cuts down the material requirements and waste compared to conventional harvest systems, leading to cost reductions and aiding sustainability objectives.
View the full report here:
What Are the Key Elements That Define the Large And Small-Scale Bioprocessing Market?
Large and small-scale bioprocessing are essential components of the biotechnology and pharmaceutical industries that involve using living cells or their components to obtain desired products, such as pharmaceuticals, chemicals, and biofuels. Large-scale bioprocessing refers to the industrial-level production of biological products involving large bioreactors and extensive infrastructure. In contrast, Small-scale bioprocessing consists of the production of biological products on a smaller scale, often for research, development, pilot studies, or niche markets.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15845
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
